|  | A |
SECTION A — HUMAN NECESSITIES

HEALTH; AMUSEMENT

|  | A61 |
MEDICAL OR VETERINARY SCIENCE; HYGIENE

|  | A61K |
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form Fulltext... Hierarchy... Expanded...A61J; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles Fulltext... Hierarchy... Expanded...A61L; compounds per se Fulltext... Hierarchy... Expanded...C01, Fulltext... Hierarchy... Expanded...C07, Fulltext... Hierarchy... Expanded...C08, Fulltext... Hierarchy... Expanded...C12N; soap compositions Fulltext... Hierarchy... Expanded...C11D; micro-organisms per se Fulltext... Hierarchy... Expanded...C12N)

|  | A61K |
Note(s) This subclass covers the following subject matter, whether set forth as a composition (mixture), process of preparing the composition or process of treating using the composition: Drug or other biological compositions which are capable of: preventing, alleviating, treating or curing abnormal or pathological conditions of the living body by such means as destroying a parasitic organism, or limiting the effect of the disease or abnormality by chemically altering the physiology of the host or parasite (biocides Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A01N 25/00-A01N 65/00); maintaining, increasing, decreasing, limiting, or destroying a physiological body function, e.g. vitamin compositions, sex sterilants, fertility inhibitors, growth promotors, or the like (plant growth regulators Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A01N 25/00-A01N 65/00); diagnosing a physiological condition or state by an in vivo test, e.g. X-ray contrast or skin patch test compositions (measuring or testing processes involving enzymes or micro-organisms Fulltext... Hierarchy... Expanded...C12Q; in vitro testing of biological material, e.g. blood, urine, Fulltext... Hierarchy... Expanded...G01N, e.g. Fulltext... Hierarchy... Expanded...G01N 33/48); Body treating compositions generally intended for deodorising, protecting, adorning or grooming a body, e.g. cosmetics, dentifrices, tooth filling materials. Attention is drawn to the definitions of groups of chemical elements following the title of section C. In this subclass, in the absence of an indication to the contrary, classification is made in the last appropriate place.

|  | A61K |
Subclass index
DENTAL PREPARATIONS | 6/00
COSMETICS, PERFUMES | 7/00
PHARMACEUTICAL PREPARATIONS |
characterised by form | 9/00
characterised by active ingredients |
organic active ingredients | 31/00, 35/00, 38/00
extracts of animal, plant, or micro-organisms | 35/00
inorganic active ingredients | 33/00, 35/00
obtained by treating material with wave energy or particle radiation | 41/00
for testing in vivo | 49/00, 51/00
radioactive ingredients | 51/00
Vaccines | 39/00, 45/00
Carriers | 47/00
Medicinal preparations with genetic material, gene therapy | 48/00

|  | A61K 6/00 |
Preparations for dentistry (teeth cleaning preparations Fulltext... Hierarchy... Expanded...A61K 7/16; dentistry Fulltext... Hierarchy... Expanded...A61C; fastening dental prostheses in the mouth using adhesive foils or adhesive compositions Fulltext... Hierarchy... Expanded...A61C 13/23) [3]

|  | A61K 6/02 |
· | Use of preparations for artificial teeth, for filling or for capping teeth [3]

|  | A61K 6/027 |
· · | Use of non-metallic elements or compounds thereof, e.g. carbon [5]

|  | A61K 6/033 |
· · · | Phosphorus compounds, e.g. apatite [5]

|  | A61K 6/04 |
· · | Use of metals or alloys (alloys per se Fulltext... Hierarchy... Expanded...C22C) [3]

|  | A61K 6/05 |
· · · | Amalgams [5]

|  | A61K 6/06 |
· · | Use of inorganic cements (cements per se Fulltext... Hierarchy... Expanded...C04B) [3]

|  | A61K 6/08 |
· · | Use of natural or synthetic resins (resins per se Fulltext... Hierarchy... Expanded...C08) [3]

|  | A61K 6/083 |
· · · | Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds [5]

|  | A61K 6/087 |
· · · | Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [5]

|  | A61K 6/09 |
· · · · | Polyurethanes [5]

|  | A61K 6/093 |
· · · · | Polyorganosilicon compounds [5]

|  | A61K 6/097 |
· · · | Polysaccharides [5]

|  | A61K 6/10 |
· | Compositions for taking dental impressions (impression methods Fulltext... Hierarchy... Expanded...A61C 9/00) [3]

|  | A61K 7/00 |
Cosmetics or similar toilet preparations (casings or accessories for storing or handling of solid or pasty toilet or cosmetic substances Fulltext... Hierarchy... Expanded...A45D 40/00)

|  | A61K 7/02 |
· | Make-up materials; Preparations for removing them; Body powders [2]

|  | A61K 7/021 |
· · | Preparations containing skin colorant (face powders Fulltext... Hierarchy... Expanded...A61K 7/035; tanning preparations Fulltext... Hierarchy... Expanded...A61K 7/42) [2]

|  | A61K 7/025 |
· · · | for lips [2]

|  | A61K 7/027 |
· · · · | Lipsticks [2]

|  | A61K 7/031 |
· · · | for cheeks, e.g. rouge [2]

|  | A61K 7/032 |
· · · | for eyes [2]

|  | A61K 7/035 |
· · | Face or body powders for grooming, adorning or absorbing [2]

|  | A61K 7/04 |
· | Manicure or pedicure compositions

|  | A61K 7/043 |
· · | Nail coatings [2]

|  | A61K 7/047 |
· · | Nail coating removers [2]

|  | A61K 7/06 |
· | Preparations, e.g. lotions or powders, for care of the hair; Preparations to promote hair growth or to aid in hair removal, e.g. shaving preparations [2]

|  | A61K 7/07 |
· · | Hair powders [2]

|  | A61K 7/075 |
· · | Preparations specially adapted for washing the hair, e.g. containing hair conditioning substances [4]

|  | A61K 7/08 |
· · | Preparations for rinsing the hair

|  | A61K 7/09 |
· · | Preparations for waving or straightening the hair [2]

|  | A61K 7/11 |
· · | Preparations for fixing the hair [2]

|  | A61K 7/13 |
· · | Preparations for dyeing the hair [2]

|  | A61K 7/135 |
· · | Preparations for bleaching the hair [2]

|  | A61K 7/15 |
· · | Shaving preparations (soaps or detergent compositions, e.g. shaving soaps, Fulltext... Hierarchy... Expanded...C11D) [2]

|  | A61K 7/155 |
· · | Depilatories [2]

|  | A61K 7/16 |
· | Preparations for cleaning the teeth or mouth, e.g. tooth-pastes; Mouthwashes

|  | A61K 7/18 |
· · | Preparations containing fluorine compounds [2]

|  | A61K 7/20 |
· · | Preparations containing compounds releasing oxygen or chlorine [2]

|  | A61K 7/22 |
· · | Preparations containing ammonia, amines or derivatives thereof, e.g. urea [2]

|  | A61K 7/24 |
· · | Preparations containing hydroxy-carboxylic acids or derivatives thereof, i.e. compounds wherein the oxygen of the hydroxy group and the carbonyl of the carboxylic acid group are retained [2]

|  | A61K 7/26 |
· · | Preparations containing plant or animal extracts, e.g. chlorophyll (Fulltext... Hierarchy... Expanded...A61K 7/28 takes precedence) [2]

|  | A61K 7/28 |
· · | Preparations containing enzymes [2]

|  | A61K 7/30 |
· · | Preparations for cleaning dentures [2]

|  | A61K 7/32 |
· | Anti-perspirants or body deodorants (deodorants for non-body applications Fulltext... Hierarchy... Expanded...A61L 9/01) [2]

|  | A61K 7/34 |
· · | Preparations containing zirconium compounds [2]

|  | A61K 7/36 |
· · | Preparations containing zinc compounds [2]

|  | A61K 7/38 |
· · | Preparations containing aluminium compounds [2]

|  | A61K 7/40 |
· | Barrier compositions; Chemical agents brought into direct contact with the skin of living human or animal bodies for affording protection against external influences, e.g. sunlight, X- or other active rays, corrosive materials, bacteria, insect stings (chemical means for combating harmful chemical agents Fulltext... Hierarchy... Expanded...A62D 3/00) [2]

|  | A61K 7/42 |
· · | Topical sun or radiation screening or tanning preparations [2]

|  | A61K 7/44 |
· · · | Preparations containing aromatic acids or derivatives thereof, e.g. aminobenzoic acid, methyl salicylate [2]

|  | A61K 7/46 |
· | Perfume compositions (essential oils, recovery thereof Fulltext... Hierarchy... Expanded...C11B 9/00) [2]

|  | A61K 7/48 |
· | Preparations for the care of the skin (Fulltext... Hierarchy... Expanded...A61K 7/02, Fulltext... Hierarchy... Expanded...A61K 7/40 take precedence) [2]

|  | A61K 7/50 |
· · | Washing or bathing preparations (soaps or detergent compositions Fulltext... Hierarchy... Expanded...C11D) [2]

|  | A61K 9/00 |
Medicinal preparations characterised by special physical form (preparations containing radioactive substances Fulltext... Hierarchy... Expanded...A61K 51/12)

|  | A61K 9/02 |
· | Suppositories; Bougies; Bases for suppositories or bougies (apparatus for making Fulltext... Hierarchy... Expanded...A61J 3/08; devices for introducing into the body Fulltext... Hierarchy... Expanded...A61M 31/00)

|  | A61K 9/06 |
· | Ointments; Bases therefor (apparatus for making Fulltext... Hierarchy... Expanded...A61J 3/04)

|  | A61K 9/08 |
· | Solutions [2,3]

|  | A61K 9/10 |
· | Dispersions; Emulsions [2,3]

|  | A61K 9/107 |
· · | Emulsions [5]

|  | A61K 9/113 |
· · · | Multiple emulsions, e.g. oil-in-water-in-oil [5]

|  | A61K 9/12 |
· · | Aerosols; Foams [2,3]

|  | A61K 9/127 |
· · | Liposomes [5]

|  | A61K 9/133 |
· · · | Unilamellar vesicles [5]

|  | A61K 9/14 |
· | Particulate form, e.g. powders (microcapsules Fulltext... Hierarchy... Expanded...A61K 9/50) [2]

|  | A61K 9/16 |
· · | Agglomerates; Granulates; Microbeadlets [2]

|  | A61K 9/18 |
· · | Adsorbates [2]

|  | A61K 9/19 |
· · | lyophilised [6]

|  | A61K 9/20 |
· | Pills, lozenges or tablets [2]

|  | A61K 9/22 |
· · | Sustained or differential release type [2]

|  | A61K 9/24 |
· · · | Layered or laminated unitary dosage forms [2]

|  | A61K 9/26 |
· · · | Discrete particles in supporting matrix [2]

|  | A61K 9/28 |
· · | Dragees; Coated pills or tablets [2]

|  | A61K 9/30 |
· · · | Organic coatings [2]

|  | A61K 9/32 |
· · · · | containing solid synthetic polymers [2]

|  | A61K 9/34 |
· · · · | containing natural gums or resins [2]

|  | A61K 9/36 |
· · · · | containing carbohydrates or derivatives thereof (Fulltext... Hierarchy... Expanded...A61K 9/34 takes precedence) [2]

|  | A61K 9/38 |
· · · · | containing proteins or derivatives thereof [2]

|  | A61K 9/40 |
· · · · · | Gelatin containing [2]

|  | A61K 9/42 |
· · · · | containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof, e.g. chocolate [2]

|  | A61K 9/44 |
· · | printed, embossed, grooved, or perforated [2]

|  | A61K 9/46 |
· · | effervescent [2]

|  | A61K 9/48 |
· | Preparations in capsules, e.g. of gelatin, of chocolate [2]

|  | A61K 9/50 |
· · | Microcapsules (Fulltext... Hierarchy... Expanded...A61K 9/52 takes precedence) [2]

|  | A61K 9/51 |
· · · | Nanocapsules [5]

|  | A61K 9/52 |
· · | Sustained or differential release type [2]

|  | A61K 9/54 |
· · · | containing discrete particles with coatings of different thicknesses or different materials [2]

|  | A61K 9/56 |
· · · · | Organic coatings [2]

|  | A61K 9/58 |
· · · · · | containing solid synthetic polymers [2]

|  | A61K 9/60 |
· · · · · | containing natural gums or resins [2]

|  | A61K 9/62 |
· · · · · | containing carbohydrates or derivatives thereof (Fulltext... Hierarchy... Expanded...A61K 9/60 takes precedence) [2]

|  | A61K 9/64 |
· · · · · | containing proteins or derivatives thereof [2]

|  | A61K 9/66 |
· · · | containing emulsions, dispersions or solutions [2]

|  | A61K 9/68 |
· | chewing gum type (processes for preparing chewing gums Fulltext... Hierarchy... Expanded...A23G 3/30) [2]

|  | A61K 9/70 |
· | Web, sheet or filament bases (bandages, dressings or absorbent pads Fulltext... Hierarchy... Expanded...A61F 13/00) [2]

|  | A61K 9/72 |
· | for smoking or inhaling [2]

|  | A61K 31/00 - A61K 47/00 |
Note(s) In groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 31/00-A61K 47/00, it is desirable to add the indexing codes relating to individual components of a composition. The indexing codes, which are chosen from the said groups, with the exception of groups Fulltext... Hierarchy... Expanded...A61K 38/54 and Fulltext... Hierarchy... Expanded...A61K 47/44, have the same numbers as the classification symbols, but a colon is used instead of the oblique stroke, and should be linked. [5] Attention is drawn to Chapter IV of the Guide which sets forth the rules concerning the application and presentation of the different types of indexing code. [6]

|  | A61K 31/00 |
Medicinal preparations containing organic active ingredients [2]

|  | A61K 31/01 |
· | Hydrocarbons [2]

|  | A61K 31/015 |
· · | carbocyclic [2]

|  | A61K 31/02 |
· | Halogenated hydrocarbons [2]

|  | A61K 31/025 |
· · | carbocyclic [2]

|  | A61K 31/03 |
· · · | aromatic [2]

|  | A61K 31/035 |
· · | having aliphatic unsaturation [2]

|  | A61K 31/04 |
· | Nitro compounds, i.e. having —NO2 groups [2]

|  | A61K 31/045 |
· | Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates [2]

|  | A61K 31/05 |
· · | Phenols [2]

|  | A61K 31/055 |
· · · | the aromatic ring being substituted by halogen [2]

|  | A61K 31/06 |
· · · | the aromatic ring being substituted by nitro groups [2]

|  | A61K 31/065 |
· · | Diphenyl-substituted acyclic alcohols [2]

|  | A61K 31/07 |
· · | Vitamin A compounds (with compounds containing 9,10-seco-cyclopenta[a]hydro-phenanthrene ring systems, e.g. vitamin D2, Fulltext... Hierarchy... Expanded...A61K 31/595) [2]

|  | A61K 31/075 |
· | Ethers or acetals [2]

|  | A61K 31/08 |
· · | acyclic, e.g. paraformaldehyde [2]

|  | A61K 31/085 |
· · | having an ether linkage to aromatic ring nuclear carbon [2]

|  | A61K 31/09 |
· · · | having two or more such linkages [2]

|  | A61K 31/095 |
· | Sulfur, selenium, or tellurium compounds, e.g. thioalcohols [2]

|  | A61K 31/10 |
· · | Thioethers; Sulfoxides; Sulfones [2]

|  | A61K 31/105 |
· · | Persulfides (thiuram disulfides Fulltext... Hierarchy... Expanded...A61K 31/145; thiosulfonic acids Fulltext... Hierarchy... Expanded...A61K 31/185) [2]

|  | A61K 31/11 |
· | Aldehydes [2]

|  | A61K 31/115 |
· · | Formaldehyde [2]

|  | A61K 31/12 |
· | Ketones [2]

|  | A61K 31/125 |
· · | Camphor; Nuclear substituted derivatives thereof [2]

|  | A61K 31/13 |
· | Amines (Fulltext... Hierarchy... Expanded...A61K 31/04 takes precedence) [2]

|  | A61K 31/135 |
· · | having benzene rings, e.g. ephedrine, epinephrines [2]

|  | A61K 31/14 |
· · | Quaternary ammonium compounds (betaines Fulltext... Hierarchy... Expanded...A61K 31/205) [2]

|  | A61K 31/145 |
· · | Thiurams [2]

|  | A61K 31/15 |
· · | Oximes; Hydrazines; Hydrazones [2]

|  | A61K 31/155 |
· · | Amidines, e.g. guanidine, isourea [2]

|  | A61K 31/16 |
· | Amides [2]

|  | A61K 31/165 |
· · | aromatic [2]

|  | A61K 31/17 |
· · | Urea or thiourea types (isourea, isothiourea Fulltext... Hierarchy... Expanded...A61K 31/155) [2]

|  | A61K 31/175 |
· · · | Carbazides; Carbazones; Semi-carbazides; Semi-carbazones; Thioanalogues thereof [2]

|  | A61K 31/18 |
· · | Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N-group Fulltext... Hierarchy... Expanded...A61K 31/63) [2]

|  | A61K 31/185 |
· | Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids [2]

|  | A61K 31/19 |
· · | Carboxylic acids; Percarboxylic acids; Salts thereof [2]

|  | A61K 31/195 |
· · · | Amino acids, e.g. pantothenic acid (proteinaceous products not degraded to individual amino acids Fulltext... Hierarchy... Expanded...A61K 38/00) [2]

|  | A61K 31/20 |
· · · | Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group [2]

|  | A61K 31/205 |
· · | Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine [2]

|  | A61K 31/21 |
· | Esters, e.g. nitroglycerine, selenocyanates [2]

|  | A61K 31/215 |
· · | of carboxylic acids [2]

|  | A61K 31/22 |
· · · | of acyclic acids [2]

|  | A61K 31/225 |
· · · · | Polycarboxylic acids [2]

|  | A61K 31/23 |
· · · · | Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group, e.g. castor oil [2]

|  | A61K 31/235 |
· · · | having an aromatic ring attached to a carboxyl group [2]

|  | A61K 31/24 |
· · · · | having an amino or nitro group [2]

|  | A61K 31/245 |
· · · · · | Amino benzoic acid types, e.g. procaine, novocaine (preparations containing salicylic acid esters Fulltext... Hierarchy... Expanded...A61K 31/60) [2]

|  | A61K 31/25 |
· · · | with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol [2]

|  | A61K 31/255 |
· · | of sulfoxy acids or sulfur analogues thereof [2]

|  | A61K 31/26 |
· · | Thiocyanate or isothiocyanate esters [2]

|  | A61K 31/265 |
· · | of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid [2]

|  | A61K 31/27 |
· · | of carbamic or thiocarbamic acids [2]

|  | A61K 31/275 |
· | Nitriles; Isonitriles [2]

|  | A61K 31/28 |
· | Compounds containing heavy metals [2]

|  | A61K 31/285 |
· · | Arsenic compounds [2]

|  | A61K 31/29 |
· · | Antimony or bismuth compounds [2]

|  | A61K 31/295 |
· · | Iron group metal compounds [2]

|  | A61K 31/30 |
· · | Copper compounds [2]

|  | A61K 31/305 |
· · | Mercury compounds [2]

|  | A61K 31/31 |
· · · | containing nitrogen [2]

|  | A61K 31/315 |
· · | Zinc compounds [2]

|  | A61K 31/32 |
· · | Tin compounds [2]

|  | A61K 31/325 |
· | Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof (thiurams Fulltext... Hierarchy... Expanded...A61K 31/145) [2]

|  | A61K 31/33 |
· | Heterocyclic compounds [2]

|  | A61K 31/335 |
· · | having oxygen as the only ring hetero atom [2]

|  | A61K 31/34 |
· · · | having five-membered rings with one oxygen as the only ring hetero atom [2]

|  | A61K 31/345 |
· · · · | Nitrofurans [2]

|  | A61K 31/35 |
· · · | having six-membered rings with one oxygen as the only ring hetero atom [2]

|  | A61K 31/355 |
· · · · | Tocopherols, e.g. vitamin E [2]

|  | A61K 31/36 |
· · · | Compounds containing methylene- dioxyphenyl groups [2]

|  | A61K 31/365 |
· · · | Lactones [2]

|  | A61K 31/37 |
· · · · | Coumarin [2]

|  | A61K 31/375 |
· · · · | Ascorbic acid, i.e. vitamin C; Salts thereof [2]

|  | A61K 31/38 |
· · | having sulfur as a ring hetero atom [2]

|  | A61K 31/385 |
· · · | having two or more sulfur atoms in the same ring [2]

|  | A61K 31/39 |
· · · | having oxygen atoms in the same ring [2]

|  | A61K 31/395 |
· · | having nitrogen as a ring hetero atom [2]

|  | A61K 31/40 |
· · · | having five-membered rings with one nitrogen as the only ring hetero atom, e.g. chlorophyll, phthalimide, hematoporphyrin [2]

|  | A61K 31/405 |
· · · · | Indole-alkanecarboxylic acids; Derivatives thereof [2]

|  | A61K 31/41 |
· · · | having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. triazoles [2]

|  | A61K 31/415 |
· · · · | Diazoles; Derivatives thereof, e.g. biotin [2]

|  | A61K 31/42 |
· · · · | Oxazoles [2]

|  | A61K 31/425 |
· · · · | Thiazoles [2]

|  | A61K 31/43 |
· · · · · | Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula , e.g. penicillins, penems [2,6]

|  | A61K 31/435 |
· · · | having six-membered rings with one nitrogen as the only ring hetero atom [2]

|  | A61K 31/44 |
· · · · | Pyridine; Derivatives thereof, e.g. vitamin B6 [2]

|  | A61K 31/445 |
· · · · · | Piperidine; Derivatives thereof [2]

|  | A61K 31/45 |
· · · · · · | Cycloheximides [2]

|  | A61K 31/455 |
· · · · · | Nicotinic acids, e.g. niacin; Derivatives thereof [2]

|  | A61K 31/46 |
· · · · · | 8-Aza-bicyclo (3,2,1) octane; Derivatives thereof, e.g. atropine, cocaine [2]

|  | A61K 31/465 |
· · · · · | Nicotine; Derivatives thereof [2]

|  | A61K 31/47 |
· · · · | Quinolines; Isoquinolines [2]

|  | A61K 31/475 |
· · · · · | having an indole ring, e.g. alkaloids such as rauwolfia, yohimbine, reserpine, strychnine [2]

|  | A61K 31/48 |
· · · · · | Ergot alkaloids, e.g. of the cyclic peptide type [2]

|  | A61K 31/485 |
· · · · · | Opium alkaloids, e.g. morphine, papaverine, codeine [2]

|  | A61K 31/49 |
· · · · · | Cinchona alkaloids, e.g. quinine [2]

|  | A61K 31/495 |
· · · | having six-membered rings with two nitrogen atoms as the only ring hetero atoms (Fulltext... Hierarchy... Expanded...A61K 31/48 takes precedence) [2]

|  | A61K 31/50 |
· · · · | Pyridazines [2]

|  | A61K 31/505 |
· · · · | Pyrimidines, e.g. uracil, quinazolone [2]

|  | A61K 31/51 |
· · · · · | Thiamines, e.g. vitamin B1 [2]

|  | A61K 31/515 |
· · · · · | Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital [2]

|  | A61K 31/52 |
· · · · · | Purines; Xanthines, e.g. caffeine, theophylline [2]

|  | A61K 31/525 |
· · · · · | Isoalloxazines, e.g. riboflavins, vitamin B2 [2]

|  | A61K 31/53 |
· · · | having six-membered rings with three nitrogens as the only ring hetero atoms [2]

|  | A61K 31/535 |
· · · | having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms [2]

|  | A61K 31/54 |
· · · | having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms [2]

|  | A61K 31/545 |
· · · · | Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula, , e.g. cephalosporins [2,6]

|  | A61K 31/55 |
· · · | having seven-membered rings [2]

|  | A61K 31/555 |
· · | containing heavy metals [2]

|  | A61K 31/557 |
· | Prostaglandins or analogues thereof, e.g. carbocyclins, prostacyclins, heteroprostaglandins [3]

|  | A61K 31/56 |
· | Compounds containing cyclopenta[a]hydrophenanthrene ring systems, including ring-modified steroids, e.g. lanolin, nor- or homo-steroids [4]

|  | A61K 31/565 |
· · | not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane [2]

|  | A61K 31/57 |
· · | substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane [2]

|  | A61K 31/575 |
· · | substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane [2]

|  | A61K 31/58 |
· · | containing heterocyclic rings [2]

|  | A61K 31/585 |
· · · | containing lactone rings [2]

|  | A61K 31/59 |
· | Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems, e.g. vitamin D2, "activated ergosterol", ergocalciferol, cholecalciferol, antirachitic vitamin [2]

|  | A61K 31/595 |
· · | with vitamin A compound (fish liver extract Fulltext... Hierarchy... Expanded...A61K 35/60) [2]

|  | A61K 31/60 |
· | Salicylic acid; Derivatives thereof, e.g. aspirin [2]

|  | A61K 31/605 |
· · | with additional oxy compounds [2]

|  | A61K 31/61 |
· · | with additional carboxylic acids, or esters or metal salts thereof [2]

|  | A61K 31/615 |
· · | with additional amines or amides [2]

|  | A61K 31/62 |
· · | with additional heterocyclic compounds [2]

|  | A61K 31/625 |
· · | having heterocyclic substituents [2]

|  | A61K 31/63 |
· | Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide p-nitrobenzene-sulfonyl-hydrazone [2]

|  | A61K 31/635 |
· · | having a heterocyclic ring [2]

|  | A61K 31/64 |
· | Sulfonylureas [2]

|  | A61K 31/645 |
· | Compounds containing a ring system of three fused rings, having an amino or amino-alkylene radical attached to the central ring [2]

|  | A61K 31/65 |
· | Tetracyclines [2]

|  | A61K 31/655 |
· | Azo, diazo, azoxy, azido or diazoamino compounds [2]

|  | A61K 31/66 |
· | Phosphorus compounds [2]

|  | A61K 31/665 |
· · | having oxygen as a ring hetero atom [2]

|  | A61K 31/67 |
· · | having sulfur as a ring hetero atom [2]

|  | A61K 31/675 |
· · | having nitrogen as a ring hetero atom [2]

|  | A61K 31/68 |
· · · | Cobalamins, e.g. vitamin B12, cyanocobalamin [2]

|  | A61K 31/685 |
· · | Amine salts of phosphorus acids, e.g. lecithin [2]

|  | A61K 31/69 |
· | Boron compounds [2]

|  | A61K 31/695 |
· | Silicon compounds [2]

|  | A61K 31/70 |
· | Carbohydrates; Derivatives thereof (Fulltext... Hierarchy... Expanded...A61K 31/68 takes precedence) [2]

|  | A61K 31/705 |
· · | Compounds containing cyclopenta[a]hydro- phenanthrene ring systems including ring-modified steroids, e.g. digitalis [4]

|  | A61K 31/71 |
· · | Fermentates, e.g. streptomycin; Such compounds synthetically prepared; Derivatives thereof [2]

|  | A61K 31/715 |
· · | Polysaccharides [2]

|  | A61K 31/72 |
· · · | Ethers; Esters [2]

|  | A61K 31/725 |
· · · | containing acid groups, e.g. heparin, agar-agar, pectin [2]

|  | A61K 31/73 |
· · · | containing amino groups (Fulltext... Hierarchy... Expanded...A61K 31/725 takes precedence) [4]

|  | A61K 31/735 |
· · · | containing substituents not provided for in groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 31/72-A61K 31/73 [2]

|  | A61K 31/74 |
· | Synthetic polymeric materials [2]

|  | A61K 31/745 |
· · | Polymers of hydrocarbons [2]

|  | A61K 31/75 |
· · · | of ethene [2]

|  | A61K 31/755 |
· · | Polymers containing halogen [2]

|  | A61K 31/76 |
· · · | of vinyl chloride [2]

|  | A61K 31/765 |
· · | Polymers containing oxygen [2]

|  | A61K 31/77 |
· · · | of oxiranes [2]

|  | A61K 31/775 |
· · · | Phenolic resins [2]

|  | A61K 31/78 |
· · · | of acrylic acid or derivatives thereof [2]

|  | A61K 31/785 |
· · | Polymers containing nitrogen [2]

|  | A61K 31/79 |
· · · | of vinyl pyrrolidone [2]

|  | A61K 31/795 |
· · | Polymers containing sulfur [2]

|  | A61K 31/80 |
· · | Polymers containing hetero atoms not provided for in groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 31/755-A61K 31/795 [2]

|  | A61K 33/00 |
Medicinal preparations containing inorganic active ingredients [2]

|  | A61K 33/02 |
· | Ammonia; Compounds thereof [2]

|  | A61K 33/04 |
· | Sulfur, selenium or tellurium; Compounds thereof [2]

|  | A61K 33/06 |
· | Aluminium, calcium or magnesium; Compounds thereof [2]

|  | A61K 33/08 |
· · | Oxides; Hydroxides [2]

|  | A61K 33/10 |
· · | Carbonates; Bicarbonates [2]

|  | A61K 33/12 |
· · | Magnesium silicate [2]

|  | A61K 33/14 |
· | Alkali metal chlorides; Alkaline earth metal chlorides [2]

|  | A61K 33/16 |
· | Fluorine compounds [2]

|  | A61K 33/18 |
· | Iodine; Compounds thereof [2]

|  | A61K 33/20 |
· | Elemental chlorine; Inorganic compounds releasing chlorine [2]

|  | A61K 33/22 |
· | Boron compounds [2]

|  | A61K 33/24 |
· | Heavy metals; Compounds thereof [2]

|  | A61K 33/26 |
· · | Iron; Compounds thereof [2]

|  | A61K 33/28 |
· · | Mercury; Compounds thereof [2]

|  | A61K 33/30 |
· · | Zinc; Compounds thereof [2]

|  | A61K 33/32 |
· · | Manganese; Compounds thereof [2]

|  | A61K 33/34 |
· · | Copper; Compounds thereof [2]

|  | A61K 33/36 |
· · | Arsenic; Compounds thereof [2]

|  | A61K 33/38 |
· · | Silver; Compounds thereof [2]

|  | A61K 33/40 |
· | Peroxides [2]

|  | A61K 33/42 |
· | Phosphorus; Compounds thereof [2]

|  | A61K 33/44 |
· | Elemental carbon, e.g. charcoal, carbon black [2]

|  | A61K 35/00 |
Medicinal preparations containing material or reaction products thereof with undetermined constitution [2]

|  | A61K 35/02 |
· | from inanimate materials [2]

|  | A61K 35/04 |
· · | Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate, e.g. Ichthyol [2]

|  | A61K 35/06 |
· · · | Mineral oils [2]

|  | A61K 35/08 |
· · | Mineral waters [2]

|  | A61K 35/10 |
· · | Peat; Amber [2]

|  | A61K 35/12 |
· | Materials from mammals or birds [2]

|  | A61K 35/14 |
· · | Blood [2]

|  | A61K 35/16 |
· · · | Plasma; Serum [2]

|  | A61K 35/18 |
· · · | Erythrocytes [2]

|  | A61K 35/20 |
· · | Milk; Colostrum [2]

|  | A61K 35/22 |
· · | Urine; Urinary system [2]

|  | A61K 35/23 |
· · · | Kidney [3]

|  | A61K 35/24 |
· · | Mucus; Mucous glands; Bursa; Arthral fluid; Excreta; Spinal fluid [2]

|  | A61K 35/26 |
· · | Lymph; Lymph-glands; Thymus [2]

|  | A61K 35/28 |
· · | Marrow; Spleen [2]

|  | A61K 35/30 |
· · | Nerves; Brain [2]

|  | A61K 35/32 |
· · | Bones; Tendons; Teeth; Cartilage (marrow Fulltext... Hierarchy... Expanded...A61K 35/28) [2]

|  | A61K 35/34 |
· · | Muscles; Heart [2]

|  | A61K 35/36 |
· · | Skin; Hair; Nails; Sebaceous glands; Cerumen (containing lanolin as active ingredient Fulltext... Hierarchy... Expanded...A61K 31/56) [4]

|  | A61K 35/37 |
· · | Digestive system [3]

|  | A61K 35/38 |
· · · | Stomach; Intestine [3]

|  | A61K 35/39 |
· · · | Pancreas [3]

|  | A61K 35/407 |
· · · | Liver [3]

|  | A61K 35/413 |
· · · | Bile [3]

|  | A61K 35/42 |
· · | Lungs [2]

|  | A61K 35/44 |
· · | Eyes; Vessels; Umbilical cord [2]

|  | A61K 35/48 |
· · | Reproductive organs; Embryos [2]

|  | A61K 35/50 |
· · · | Placenta; Amniotic fluid [2]

|  | A61K 35/52 |
· · · | Sperm [2]

|  | A61K 35/54 |
· · · | Ovary; Eggs; Embryos [2]

|  | A61K 35/55 |
· · | Glands not provided for in one of the preceding subgroups of this main group [3]

|  | A61K 35/56 |
· | Materials from animals other than mammals or birds [2]

|  | A61K 35/58 |
· · | Snakes (antigens Fulltext... Hierarchy... Expanded...A61K 39/38) [2]

|  | A61K 35/60 |
· · | Fish (vitamin A Fulltext... Hierarchy... Expanded...A61K 31/07; vitamin D Fulltext... Hierarchy... Expanded...A61K 31/59) [2]

|  | A61K 35/62 |
· · | Leeches [2]

|  | A61K 35/64 |
· · | Insects, e.g. royal jelly [2]

|  | A61K 35/66 |
· | Materials from micro-organisms [2]

|  | A61K 35/68 |
· · | Protozoa [2]

|  | A61K 35/70 |
· · | Lower fungi [2]

|  | A61K 35/72 |
· · | Yeasts [2]

|  | A61K 35/74 |
· · | Bacteria [2]

|  | A61K 35/76 |
· · | Viruses [2]

|  | A61K 35/78 |
· | Materials from plants [2]

|  | A61K 35/80 |
· · | Algae [2]

|  | A61K 35/82 |
· · | Lichens [2]

|  | A61K 35/84 |
· · | Higher fungi [2]

|  | A61K 37/00 - A61K 37/02 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/00 )

|  | A61K 37/04 - A61K 37/10 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/16 )

|  | A61K 37/12 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/17, Fulltext... Hierarchy... Expanded...A61K 38/36, Fulltext... Hierarchy... Expanded...A61K 38/39 )

|  | A61K 37/14 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/16 )

|  | A61K 37/16 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/17 )

|  | A61K 37/18 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/00, covered by Fulltext... Hierarchy... Expanded...A61K 31/00 )

|  | A61K 37/20 |
( covered by Fulltext... Hierarchy... Expanded...A61K 31/715 )

|  | A61K 37/22 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/00, covered by Fulltext... Hierarchy... Expanded...A61K 31/00, Fulltext... Hierarchy... Expanded...A61K 35/00 )

|  | A61K 37/24 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/08, Fulltext... Hierarchy... Expanded...A61K 38/22 )

|  | A61K 37/26 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/28 )

|  | A61K 37/28 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/26 )

|  | A61K 37/30 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/23 )

|  | A61K 37/32 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/22 )

|  | A61K 37/34 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/11 )

|  | A61K 37/36 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/27 )

|  | A61K 37/38 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/24 )

|  | A61K 37/40 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/35 )

|  | A61K 37/42 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/17 )

|  | A61K 37/43 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/04 )

|  | A61K 37/46 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/36 )

|  | A61K 37/465 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/43 )

|  | A61K 37/47 - A61K 37/475 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/48 )

|  | A61K 37/48 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/43 )

|  | A61K 37/50 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/44 )

|  | A61K 37/52 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/45 )

|  | A61K 37/54 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/46 )

|  | A61K 37/547 - A61K 37/553 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/48 )

|  | A61K 37/56 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/51 )

|  | A61K 37/58 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/52 )

|  | A61K 37/60 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/53 )

|  | A61K 37/62 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/54 )

|  | A61K 37/64 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/55 )

|  | A61K 37/66 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 38/21 )

|  | A61K 38/00 |
Medicinal preparations containing peptides (peptides containing beta-lactam rings Fulltext... Hierarchy... Expanded...A61K 31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, Fulltext... Hierarchy... Expanded...A61K 31/00; ergot alkaloids of the cyclic peptide type Fulltext... Hierarchy... Expanded...A61K 31/48; containing macromolecular compounds having statistically distributed amino acid units Fulltext... Hierarchy... Expanded...A61K 31/74; medicinal preparations containing antigens or antibodies Fulltext... Hierarchy... Expanded...A61K 39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, Fulltext... Hierarchy... Expanded...A61K 47/00) [6]

|  | A61K 38/00 |
Note(s) The terms or expressions used in this group follow exactly the definitions given in Note (1) following the title of subclass Fulltext... Hierarchy... Expanded...C07K. [6] Preparations containing fragments of peptides or peptides modified by removal or addition of amino acids, by substitution of amino acids by others, or by combination of these modifications are classified as the preparations containing parent peptides. However, preparations containing fragments of peptides having only four or less amino acids are also classified in groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 38/05-A61K 38/07. [6] Preparations containing peptides prepared by recombinant DNA technology are not classified according to the host, but according to the original peptide expressed, e.g. preparations containing HIV peptide expressed in E. coli are classified with the preparations containing HIV peptides. [6]

|  | A61K 38/01 |
· | Hydrolysed proteins; Derivatives thereof [6]

|  | A61K 38/02 |
· | Peptides of undefined number of amino acids; Derivatives thereof [6]

|  | A61K 38/03 |
· | Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof [6]

|  | A61K 38/04 |
· | Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (gastrins Fulltext... Hierarchy... Expanded...A61K 38/16, somatostatins Fulltext... Hierarchy... Expanded...A61K 38/31, melanotropins Fulltext... Hierarchy... Expanded...A61K 38/34) [6]

|  | A61K 38/05 |
· · | Dipeptides [6]

|  | A61K 38/06 |
· · | Tripeptides [6]

|  | A61K 38/07 |
· · | Tetrapeptides [6]

|  | A61K 38/08 |
· · | Peptides having 5 to 11 amino acids [6]

|  | A61K 38/09 |
· · · | Luteinising hormone-releasing hormone (LHRH); Related peptides [6]

|  | A61K 38/10 |
· · | Peptides having 12 to 20 amino acids [6]

|  | A61K 38/11 |
· · · | Oxytocins; Vasopressins; Related peptides [6]

|  | A61K 38/12 |
· · | Cyclic peptides [6]

|  | A61K 38/13 |
· · · | Cyclosporins [6]

|  | A61K 38/14 |
· · | Peptides containing saccharide radicals; Derivatives thereof [6]

|  | A61K 38/15 |
· · | Depsipeptides; Derivatives thereof [6]

|  | A61K 38/16 |
· | Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof [6]

|  | A61K 38/17 |
· · | from animals; from humans [6]

|  | A61K 38/18 |
· · · | Growth factors; Growth regulators [6]

|  | A61K 38/19 |
· · · | Cytokines; Lymphokines; Interferons [6]

|  | A61K 38/20 |
· · · · | Interleukins [6]

|  | A61K 38/21 |
· · · · | Interferons [6]

|  | A61K 38/22 |
· · · | Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin Fulltext... Hierarchy... Expanded...A61K 38/33, e.g. corticotropin Fulltext... Hierarchy... Expanded...A61K 38/35) [6]

|  | A61K 38/23 |
· · · · | Calcitonins [6]

|  | A61K 38/24 |
· · · · | Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH) [6]

|  | A61K 38/25 |
· · · · | Growth hormone-releasing factor (GH-RF) (Somatoliberin) [6]

|  | A61K 38/26 |
· · · · | Glucagons [6]

|  | A61K 38/27 |
· · · · | Growth hormone (GH) (Somatotropin) [6]

|  | A61K 38/28 |
· · · · | Insulins [6]

|  | A61K 38/29 |
· · · · | Parathyroid hormone (parathormone); Parathyroid hormone-related peptides [6]

|  | A61K 38/30 |
· · · · | Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2 [6]

|  | A61K 38/31 |
· · · · | Somatostatins [6]

|  | A61K 38/32 |
· · · · | Thymopoietins [6]

|  | A61K 38/33 |
· · · | derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin [6]

|  | A61K 38/34 |
· · · · | Melanocyte stimulating hormone (MSH), e.g. alpha- or beta-melanotropin [6]

|  | A61K 38/35 |
· · · · | Corticotropin (ACTH) [6]

|  | A61K 38/36 |
· · · | Blood coagulation or fibrinolysis factors [6]

|  | A61K 38/37 |
· · · · | Factors VIII [6]

|  | A61K 38/38 |
· · · | Albumins [6]

|  | A61K 38/39 |
· · · | Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG) [6]

|  | A61K 38/40 |
· · · | Transferrins, e.g. lactoferrins, ovotransferrins [6]

|  | A61K 38/41 |
· · | Porphyrin- or corrin-ring-containing peptides [6]

|  | A61K 38/42 |
· · · | Haemoglobins; Myoglobins [6]

|  | A61K 38/43 |
· · | Enzymes; Proenzymes; Derivatives thereof [6]

|  | A61K 38/43 |
Note(s) In this group: [6] proenzymes are classified with the corresponding enzymes; [6] enzymes are generally categorised according to the "Nomenclature and Classification of Enzymes" of the International Commission of Enzymes. Where appropriate, this designation appears in the subgroups below in parenthesis. [6]

|  | A61K 38/44 |
· · · | Oxidoreductases (1) [6]

|  | A61K 38/45 |
· · · | Transferases (2) [6]

|  | A61K 38/46 |
· · · | Hydrolases (3) [6]

|  | A61K 38/47 |
· · · · | acting on glycosyl compounds (3.2), e.g. cellulases, lactases [6]

|  | A61K 38/48 |
· · · · | acting on peptide bonds (3.4) [6]

|  | A61K 38/49 |
· · · · · | Urokinase; Tissue plasminogen activator [6]

|  | A61K 38/50 |
· · · · | acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase [6]

|  | A61K 38/51 |
· · · | Lyases (4) [6]

|  | A61K 38/52 |
· · · | Isomerases (5) [6]

|  | A61K 38/53 |
· · · | Ligases (6) [6]

|  | A61K 38/54 |
· · · | Mixtures of enzymes or proenzymes covered by more than a single one of groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 38/44-A61K 38/46 or Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 38/51-A61K 38/53 [6]

|  | A61K 38/55 |
· · | Protease inhibitors [6]

|  | A61K 38/56 |
· · · | from plants [6]

|  | A61K 38/57 |
· · · | from animals; from humans [6]

|  | A61K 38/58 |
· · · · | from leeches, e.g. hirudin, eglin [6]

|  | A61K 39/00 |
Medicinal preparations containing antigens or antibodies (materials for immunoassay Fulltext... Hierarchy... Expanded...G01N 33/53) [2]

|  | A61K 39/002 - A61K 39/295 |
Note(s) Groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 39/002-A61K 39/295 cover preparations containing protozoa, bacteria, viruses, or subunits thereof, e.g. membrane parts. [3] Preparation of antigen or antibody compositions is also classified in subclass Fulltext... Hierarchy... Expanded...C12N, if the step of cultivating the micro-organism is of interest. [3]

|  | A61K 39/002 |
· | Protozoa antigens [3]

|  | A61K 39/005 |
· · | Trypanosoma antigens [3]

|  | A61K 39/008 |
· · | Leishmania antigens [3]

|  | A61K 39/012 |
· · | Coccidia antigens [3]

|  | A61K 39/015 |
· · | Hemosporidia antigens, e.g. Plasmodium antigens [3]

|  | A61K 39/018 |
· · · | Babesia antigens, e.g. Theileria antigens [3]

|  | A61K 39/02 |
· | Bacterial antigens [2]

|  | A61K 39/04 |
· · | Mycobacterium, e.g. Mycobacterium tuberculosis [2,3]

|  | A61K 39/05 |
· · | Corynebacterium; Propionibacterium [3]

|  | A61K 39/07 |
· · | Bacillus [3]

|  | A61K 39/08 |
· · | Clostridium, e.g. Clostridium tetani [2]

|  | A61K 39/085 |
· · | Staphylococcus [3]

|  | A61K 39/09 |
· · | Streptococcus [3]

|  | A61K 39/095 |
· · | Neisseria [3]

|  | A61K 39/10 |
· · | Brucella; Bordetella, e.g. Bordetella pertussis [2,3]

|  | A61K 39/102 |
· · | Pasteurella; Haemophilus [3]

|  | A61K 39/104 |
· · | Pseudomonas [3]

|  | A61K 39/106 |
· · | Vibrio; Campylobacter [3]

|  | A61K 39/108 |
· · | Escherichia; Klebsiella [3]

|  | A61K 39/112 |
· · | Salmonella; Shigella [3]

|  | A61K 39/114 |
· · | Fusobacterium [3]

|  | A61K 39/116 |
· · | Polyvalent bacterial antigens [3]

|  | A61K 39/118 |
· | Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci [3]

|  | A61K 39/12 |
· | Viral antigens [2]

|  | A61K 39/125 |
· · | Picornaviridae, e.g. calicivirus [3]

|  | A61K 39/13 |
· · · | Poliovirus [3]

|  | A61K 39/135 |
· · · | Foot-and-mouth disease virus [3]

|  | A61K 39/145 |
· · | Orthomyxoviridae, e.g. influenza virus [3]

|  | A61K 39/15 |
· · | Reoviridae, e.g. calf diarrhea virus [3]

|  | A61K 39/155 |
· · | Paramyxoviridae, e.g. parainfluenza virus [3]

|  | A61K 39/165 |
· · · | Mumps or measles virus [3]

|  | A61K 39/17 |
· · · | Newcastle disease virus [3]

|  | A61K 39/175 |
· · · | Canine distemper virus [3]

|  | A61K 39/187 |
· · | Hog cholera virus [3]

|  | A61K 39/193 |
· · | Equine encephalomyelitis virus [3]

|  | A61K 39/20 |
· · | Rubella virus [2]

|  | A61K 39/205 |
· · | Rhabdoviridae, e.g. rabies virus [3]

|  | A61K 39/21 |
· · | Retroviridae, e.g. equine infectious anemia virus [3]

|  | A61K 39/215 |
· · | Coronaviridae, e.g. avian infectious bronchitis virus [3]

|  | A61K 39/225 |
· · · | Porcine transmissible gastroenteritis virus [3]

|  | A61K 39/23 |
· · | Parvoviridae, e.g. feline panleukopenia virus [3]

|  | A61K 39/235 |
· · | Adenoviridae [3]

|  | A61K 39/245 |
· · | Herpetoviridae, e.g. herpes simplex virus [3]

|  | A61K 39/25 |
· · · | Varicella-zoster virus [3]

|  | A61K 39/255 |
· · · | Marek's disease virus [3]

|  | A61K 39/265 |
· · · | Infectious rhinotracheitis virus [3]

|  | A61K 39/27 |
· · · | Equine rhinopneumonitis virus [3]

|  | A61K 39/275 |
· · | Poxviridae, e.g. avipoxvirus [3]

|  | A61K 39/285 |
· · · | Vaccinia virus or variola virus [3]

|  | A61K 39/29 |
· · | Hepatitis virus [3]

|  | A61K 39/295 |
· · | Polyvalent viral antigens (vaccinia virus or variola virus Fulltext... Hierarchy... Expanded...A61K 39/285); Mixtures of viral and bacterial antigens [3]

|  | A61K 39/35 |
· | Allergens [3]

|  | A61K 39/36 |
· · | from pollen [2,3]

|  | A61K 39/38 |
· | Antigens from snakes [2]

|  | A61K 39/385 |
· | Haptens or antigens, bound to carriers [3]

|  | A61K 39/39 |
· | characterised by the immunostimulating additives, e.g. chemical adjuvants [3]

|  | A61K 39/395 |
· | Antibodies (agglutinins Fulltext... Hierarchy... Expanded...A61K 38/36); Immunoglobulins; Immune serum, e.g. antilymphocytic serum [3]

|  | A61K 39/40 |
· · | bacterial [2,3]

|  | A61K 39/42 |
· · | viral [2,3]

|  | A61K 39/44 |
· · | Antibodies bound to carriers [2,3]

|  | A61K 41/00 |
Medicinal preparations obtained by treating materials with wave energy or particle radiation (Fulltext... Hierarchy... Expanded...A61K 31/59 takes precedence; electric discharge tubes Fulltext... Hierarchy... Expanded...H01J) [2]

|  | A61K 43/00 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 51/00 )

|  | A61K 45/00 |
Medicinal preparations containing active ingredients not provided for in groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 31/00-A61K 41/00 [2,6]

|  | A61K 45/05 |
· | Immunological preparations stimulating the recticulo-endothelial system, e.g. against cancer [3]

|  | A61K 45/06 |
· | Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca [2]

|  | A61K 45/08 |
· | Mixtures of an active ingredient and an auxiliary substance neither being chemically characterised, e.g. antihistaminicum and surface active substance [2]

|  | A61K 47/00 |
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives [2]

|  | A61K 47/02 |
· | Inorganic compounds [5]

|  | A61K 47/04 |
· · | Non-metals; Compounds thereof [5]

|  | A61K 47/06 |
· | Organic compounds [5]

|  | A61K 47/08 |
· · | containing oxygen [5]

|  | A61K 47/10 |
· · · | Alcohols; Phenols; Salts thereof [5]

|  | A61K 47/12 |
· · · | Carboxylic acids; Salts or anhydrides thereof [5]

|  | A61K 47/14 |
· · · | Esters of carboxylic acids [5]

|  | A61K 47/16 |
· · | containing nitrogen [5]

|  | A61K 47/18 |
· · · | Amines; Quaternary ammonium compounds [5]

|  | A61K 47/20 |
· · | containing sulfur [5]

|  | A61K 47/22 |
· · | Heterocyclic compounds [5]

|  | A61K 47/24 |
· · | containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur [5]

|  | A61K 47/26 |
· · | Carbohydrates [5]

|  | A61K 47/28 |
· · | Steroids [5]

|  | A61K 47/30 |
· | Macromolecular compounds [5]

|  | A61K 47/32 |
· · | Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds [5]

|  | A61K 47/34 |
· · | Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [5]

|  | A61K 47/36 |
· · | Polysaccharides; Derivatives thereof [5]

|  | A61K 47/38 |
· · · | Cellulose; Derivatives thereof [5]

|  | A61K 47/40 |
· · · | Cyclodextrins; Derivatives thereof [5]

|  | A61K 47/42 |
· · | Proteins; Polypeptides; Degradation products thereof; Derivatives thereof [5]

|  | A61K 47/44 |
· | Oils, fats or waxes according to more than one of groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 47/02-A61K 47/42 [5]

|  | A61K 47/46 |
· | Ingredients of undetermined constitution or reaction products thereof [5]

|  | A61K 47/48 |
· | the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates [5]

|  | A61K 48/00 |
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy [5]

|  | A61K 49/00 |
Preparations for testing in vivo [3]

|  | A61K 49/02 |
( transferred to Fulltext... Hierarchy... Expanded...A61K 51/00 )

|  | A61K 49/04 |
· | X-ray contrast preparations [3]

|  | A61K 51/00 |
Preparations containing radioactive substances for use in therapy or testing in vivo [6]

|  | A61K 51/00 |
Note(s) In this group, it is desirable to add the indexing codes of groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...A61K 101/00-A61K 123/00. The indexing codes should be unlinked. [6]

|  | A61K 51/02 |
· | characterised by the carrier [6]

|  | A61K 51/04 |
· · | Organic compounds [6]

|  | A61K 51/06 |
· · · | Macromolecular compounds [6]

|  | A61K 51/08 |
· · · | Peptides, e.g. proteins [6]

|  | A61K 51/10 |
· · · · | Antibodies or immunoglobulins; Fragments thereof [6]

|  | A61K 51/12 |
· | characterised by a special physical form, e.g. emulsion, microcapsules, liposomes [6]

|  | A61K 101/00 - A61K 123/00 |
Indexing scheme associated with group Fulltext... Hierarchy... Expanded...A61K 51/00, relating to the nature or the activity of the radioactive substance. The indexing codes should be unlinked. [6]

|  | A61K 101/00 - A61K 123/00 |
Note(s) Attention is drawn to Chapter IV of the Guide which sets forth the rules concerning the application and presentation of the different types of indexing code. [6]

|  | A61K 101/00 |
Radioactive non-metals [6]

|  | A61K 101/02 |
· | Halogens [6]

|  | A61K 103/00 |
Radioactive metals [6]

|  | A61K 103/10 |
· | Technetium; Rhenium [6]

|  | A61K 103/20 |
· | Indium [6]

|  | A61K 103/30 |
· | Rare earths [6]

|  | A61K 103/32 |
· · | Yttrium [6]

|  | A61K 103/34 |
· · | Gadolinium [6]

|  | A61K 103/36 |
· · | Ytterbium [6]

|  | A61K 103/40 |
· | Actinides [6]

|  | A61K 121/00 |
Preparations for use in therapy [6]

|  | A61K 123/00 |
Preparations for testing in vivo [6]